"10.1371_journal.pone.0018048","plos one","2011-03-28T00:00:00Z","Lorenz Bott-Flügel; Alexandra Bernshausen; Heike Schneider; Peter Luppa; Katja Zimmermann; Barbara Albrecht-Küpper; Raimund Kast; Karl-Ludwig Laugwitz; Heimo Ehmke; Andreas Knorr; Melchior Seyfarth","1. Medizinische Klinik, Klinikum rechts der Isar and Deutsches Herzzentrum München, Technische Universität, München, Germany; Institut für Klinische Chemie und Pathobiochemie, Klinikum rechts der Isar, Technische Universität, München, Germany; Bayer Schering Pharma AG, Global Drug Discovery, Wuppertal, Germany; Institut für Vegetative Physiologie und Pathophysiologie, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany; Medizinische Klinik 3, HELIOS Klinikum Wuppertal and Lehrstuhl für Kardiologie, Universität Witten/Herdecke, Witten, Germany","Conceived and designed the experiments: LBF KCZ KLL HE AK MS. Performed the experiments: LBF AB HS KCZ BAK RK. Analyzed the data: LBF HS PL KCZ BAK RK KLL HE AK MS. Contributed reagents/materials/analysis tools: HS KCZ AK. Wrote the paper: LBF HE MS.","L. Bott-Flügel received travel fees from Bayer Schering Pharma GmbH. H. Ehmke serves as consultant to Bayer Schering Pharma GmbH. K. Zimmermann, A. Knorr, B. Albrecht-Küpper, and R. Kast are employees of Bayer Schering Pharma GmbH. Bayer Schering Pharma provided funding for the in vivo studies and took part in the design, data aquisition and analysis of the in vivo experiments. The principal investigators (L. Bott-Flügel, H. Ehmke, and Melchior Seyfarth) had access to the raw data, and Bayer Schering had no role in the interpretation of the data and decision to publish. The authors declare that funding by Bayer Schering Pharma does not influence their adherence to the PLoS ONE policies on sharing data and materials.","2011","03","Lorenz Bott-Flügel","LBF",11,TRUE,6,6,10,3,TRUE,TRUE,FALSE,0,NA,FALSE
